(IN BRIEF) A new study led by researchers at The Institute of Cancer Research, London, has identified a promising new…
(IN BRIEF) The Institute of Cancer Research has renewed its Athena Swan Silver Award for 2025–2029, recognising continued progress in…
Europe’s RNA immunotherapy sector is gaining speed with new in vivo CAR-T and mRNA vaccine trials. Germany approved the region’s…
Rebrand: Myeloid Therapeutics becomes CREATE Medicines, reflecting a shift to multi-lineage RNA immune programming. Scientific Focus: Expanding beyond myeloid cells…
(IN BRIEF) AstraZeneca reported positive Phase III Bax24 trial results showing that baxdrostat achieved a significant and clinically meaningful reduction…
(IN BRIEF) FIGO has presented the 2025 FIGO Women’s Awards to nineteen exceptional women from around the world for their…
(IN BRIEF) The International Federation of Gynecology and Obstetrics (FIGO) has expanded its international network to 142 national societies with…
(IN BRIEF) FIGO will host over 5,000 participants at the XXV FIGO World Congress of Gynecology and Obstetrics, held in…
(IN BRIEF) At the XXIII FIGO World Congress of Gynecology and Obstetrics in Cape Town, six outstanding figures were honoured…
CREATE Medicines (“CREATE”) broadens clinical programs and capabilities to expand therapeutic potential and improve patient outcomes Therapies tolerably program immune…